You are using an older browser version. Please use a supported version for the best MSN experience.

ETF Growth Opportunities in Chinese Biotech

Jun.19 -- Bloomberg's Eric Balchunas and Scarlet Fu break down the Loncar China Biopharma ETF (ticker: CHNA) with Brad Loncar, CEO of Loncar Investments. They discuss growth prospects in the space.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon